GLPwatch
Ozempic vs Victoza
Drug comparison
Last updated 2026-05-28 15:46 UTCOzempic and Victoza are both injectable medications made by Novo Nordisk to treat type 2 diabetes and reduce cardiovascular risk. Ozempic uses the active ingredient semaglutide, while Victoza uses liraglutide. Both are given as under-the-skin shots, but Ozempic is taken weekly while Victoza is taken daily.
AI summary of the sources below.
| Ozempic | Victoza | |
|---|---|---|
| Active ingredient | semaglutide | liraglutide |
| Manufacturer | novo-nordisk | novo-nordisk |
| Route | subcutaneous injection | subcutaneous injection |
| FDA-approved for | type 2 diabetes, cardiovascular risk reduction, chronic kidney disease | type 2 diabetes, cardiovascular risk reduction |
| Label updated | 2026-01-30 | 2023-02-06 |